- Home
- CDIO vs CNFR Comparison
CDIO vs CNFR Comparison
Compare CDIO & CNFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- CNFR
- Stock Information
- Founded
- CDIO 2017
- CNFR 2009
- Country
- CDIO United States
- CNFR United States
- Employees
- CDIO N/A
- CNFR N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- CNFR Property-Casualty Insurers
- Sector
- CDIO Health Care
- CNFR Finance
- Exchange
- CDIO Nasdaq
- CNFR Nasdaq
- Market Cap
- CDIO 7.0M
- CNFR 7.9M
- IPO Year
- CDIO N/A
- CNFR 2015
- Fundamental
- Price
- CDIO $4.77
- CNFR $0.76
- Analyst Decision
- CDIO Buy
- CNFR
- Analyst Count
- CDIO 1
- CNFR 0
- Target Price
- CDIO $60.00
- CNFR N/A
- AVG Volume (30 Days)
- CDIO 102.5K
- CNFR 11.0K
- Earning Date
- CDIO 05-15-2025
- CNFR 05-14-2025
- Dividend Yield
- CDIO N/A
- CNFR N/A
- EPS Growth
- CDIO N/A
- CNFR N/A
- EPS
- CDIO N/A
- CNFR 1.96
- Revenue
- CDIO $19,902.00
- CNFR $64,021,000.00
- Revenue This Year
- CDIO $1,434.82
- CNFR $25.91
- Revenue Next Year
- CDIO $4,661.91
- CNFR N/A
- P/E Ratio
- CDIO N/A
- CNFR $0.39
- Revenue Growth
- CDIO N/A
- CNFR N/A
- 52 Week Low
- CDIO $3.40
- CNFR $0.42
- 52 Week High
- CDIO $53.10
- CNFR $1.91
- Technical
- Relative Strength Index (RSI)
- CDIO 39.92
- CNFR 47.88
- Support Level
- CDIO $3.88
- CNFR $0.75
- Resistance Level
- CDIO $5.20
- CNFR $0.85
- Average True Range (ATR)
- CDIO 0.48
- CNFR 0.03
- MACD
- CDIO 0.32
- CNFR -0.01
- Stochastic Oscillator
- CDIO 68.25
- CNFR 18.85
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About CNFR Conifer Holdings Inc.
Conifer Holdings Inc is an insurance holding company. The company markets and services the product offerings of the company through specialty personal insurance business lines. The company offers insurance products in Texas, Illinois, and Indiana for homeowners lines and Nevada and Michigan for other lines. The revenues of the company are derived from premiums earned from insurance operations.